Another source of outcomes data?

I hadn't heard of this before, but it doesn't surprise me: Drug companies turn to 'Pharma 2.0' (World News Australia). From the article:

    By using smart gadgets to monitor patients in real time, pharmaceutical companies believe they can improve clinical outcomes and establish the cost-effectiveness of treatments.

    The result, according to a report on Thursday from Ernst & Young, will be a host of new collaborations between pharmaceutical companies and businesses in non-traditional areas such as computing, telecoms and even retail.

It also cites examples already in use, such as Bayer's "connecting its glucometer for diabetic children to Nintendo's video-gaming consoles to promote consistent blood sugar testing." Putting some disquieting implications aside, this could provide a whole new source of outcomes data for everyone involved (including, one would think, CME providers).

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish